Page last updated: 2024-10-30

mechlorethamine and Demyelinating Diseases

mechlorethamine has been researched along with Demyelinating Diseases in 1 studies

nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.

Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.

Research Excerpts

ExcerptRelevanceReference
"Treatment of Hodgkin's disease resulted in complete remission and complete disappearance of the pontine abnormality."1.29Hodgkin's disease associated with central pontine myelinolysis. ( Carrol, CL; Chintagumpala, MM; Dreyer, ZE; Fishman, MA; Mahoney, DH; McClain, K; Steuber, CP, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chintagumpala, MM1
Mahoney, DH1
McClain, K1
Dreyer, ZE1
Fishman, MA1
Carrol, CL1
Steuber, CP1

Other Studies

1 other study available for mechlorethamine and Demyelinating Diseases

ArticleYear
Hodgkin's disease associated with central pontine myelinolysis.
    Medical and pediatric oncology, 1993, Volume: 21, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Demyelinating Disease

1993